NEW YORK (Reuters Health) – In the emergency department, successful intubation on the first try is equally likely using either succinylcholine at a median dose of 1.65 mg/kg…
NEW YORK (Reuters Health) – A new meta-analysis shows adjunctive subcutaneous omalizumab may help patients with uncontrolled allergic asthma withdraw from or cut back on corticosteroids. Researchers also…
NEW YORK (Reuters Health) – For conversion of recent-onset atrial fibrillation, vernakalant acted more rapidly and was more effective than amiodarone in an international study. As reported in…
NEW YORK (Reuters Health) – Premature infants of < 34 weeks’ gestation on respiratory support should not be treated with inhaled nitric oxide, according to a new consensus…
NEW YORK (Reuters Health) – Dabigatran (Pradaxa, Boehringer Ingelheim) is as effective as warfarin in preventing stroke and systemic embolism after cardioversion in patients with nonvalvular atrial fibrillation,…
Doctors often prescribe unfractionated heparin to obese patients with venous thromboembolism below the recommended doses based on body weight, according to a new study. As a result, some…
NEW YORK (Reuters Health) – The authors of a systematic review and meta-analysis of relevant studies encourage clinicians to exercise good judgment in using the injectable antibiotic tigecycline…
NEW YORK (Reuters Health) – In patients with chronic stable heart failure (HF) due to nonischemic dilated cardiomyopathy, a year’s treatment with n-3 polyunsaturated fatty acids (n-3 PUFAs)…
NEW YORK (Reuters Health) – Anticoagulation with low-molecular-weight heparin (LMWH) dalteparin following heart valve surgery leads to fewer adverse events than does unfractionated heparin, Canadian researchers report in…
NEW YORK (Reuters Health) – Alpha-blockers and antibiotics relieve symptoms of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) better than other therapies, according to a network meta-analysis in the…